Patents by Inventor Irena Pulte

Irena Pulte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIGH DOSE AND LOW VOLUME BOTULINUM TOXIN TREATMENT OF FACIAL WRINKLES
    Publication number: 20230329996
    Abstract: The present invention relates the use of botulinum toxin for the treatment of facial wrinkles, wherein botulinum toxin is administered at high doses (e.g., 50 U to 200 U) using small injection volumes (e.g., 0.05 ml to 0.35 ml). Furthermore, the present invention relates to a method for the treatment of facial wrinkles (e.g., glabellar frown lines) by injecting small volumes of a highly concentrated botulinum toxin solution into a target facial area of a subject.
    Type: Application
    Filed: June 4, 2021
    Publication date: October 19, 2023
    Inventors: Susanna ROLL, Meik SLADEK, Thorin GEISTER, Irena PULTE, Petra WEISSENBERGER, Gudrun KLEIN
  • USE OF BOTULINUM NEUROTOXIN IN THE TREATMENT OF SIALORRHEA
    Publication number: 20230270829
    Abstract: This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1.
    Type: Application
    Filed: November 10, 2022
    Publication date: August 31, 2023
    Inventors: Janos CSIKOS, Irena PULTE, Michael ALTHAUS, Markus KRUEER, Nico WEGENER
  • Use of botulinum neurotoxin in the treatment of sialorrhea
    Patent number: 11529398
    Abstract: This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: December 20, 2022
    Assignee: MERZ PHARMA GMBH & CO. KGAA
    Inventors: Janos Csikos, Irena Pulte, Michael Althaus, Markus Krueer, Nico Wegener
  • NOVEL USES OF BOTULINUM NEUROTOXIN FOR THE TREATMENT OF TREMOR
    Publication number: 20220143157
    Abstract: This invention relates to novel uses of botulinum neurotoxin in treating a tremor, in particular to a botulinum neurotoxin for use in treating a tremor of the upper limb comprising the administration of a botulinum neurotoxin to at least one muscle of the forearm/wrist, elbow and shoulder, wherein the botulinum neurotoxin is administered to at least one muscle of the forearm/wrist selected from the group of M. extensor carpi ulnaris (ECU), M. extensor carpi radialis (ECR), M. pronator quadratus (PQ) and M. supinator in a dosage in the range of 2 to 6 U and wherein the botulinum neurotoxin is administered to at least one muscle of the elbow in a dosage of about 20 U and to at least one muscle of the shoulder in a dosage of about 15 U.
    Type: Application
    Filed: February 18, 2020
    Publication date: May 12, 2022
    Inventors: Janos CSIKOS, Irena PULTE, Reinhard HIERSEMENZEL, Michael ALTHAUS, Christiane NALASKOWSKI, David SIMPSON, Bahman JABBARI, Mandar JOG, Jack LEE
  • USE OF BOTULINUM NEUROTOXIN IN THE TREATMENT OF SIALORRHEA
    Publication number: 20200297823
    Abstract: This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1.
    Type: Application
    Filed: June 5, 2020
    Publication date: September 24, 2020
    Inventors: Janos CSIKOS, Irena PULTE, Michael ALTHAUS, Markus KRUEER, Nico WEGENER
  • Use of botulinum neurotoxin in the treatment of sialorrhea
    Patent number: 10709772
    Abstract: This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: July 14, 2020
    Assignee: Merz Pharma GmbH & Co. KGaA
    Inventors: Janos Csikos, Irena Pulte, Michael Althaus, Markus Krüer, Nico Wegener
  • USE OF BOTULINUM NEUROTOXIN IN THE TREATMENT OF SIALORRHEA
    Publication number: 20190000938
    Abstract: This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1.
    Type: Application
    Filed: September 12, 2018
    Publication date: January 3, 2019
    Inventors: Janos CSIKOS, Irena PULTE, Michael ALTHAUS, Markus KRÜER, Nico WEGENER
  • Neramexane for the treatment or prevention of inner ear disorders
    Publication number: 20110294890
    Abstract: The present invention relates to a method of treatment or prevention of an inner ear disorder in a female comprising administering a therapeutically effective amount of neramexane or a pharmaceutically acceptable salt thereof to a female.
    Type: Application
    Filed: May 25, 2011
    Publication date: December 1, 2011
    Applicant: MERZ PHARMA GmbH & CO. KGaA
    Inventors: Michael Althaus, Barbara Ellers-Lenz, Irena Pulte